Literature DB >> 21727932

Prevention: MAPping out breast cancer chemoprevention.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2011        PMID: 21727932     DOI: 10.1038/nrclinonc.2011.102

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Exemestane for breast-cancer prevention in postmenopausal women.

Authors:  Paul E Goss; James N Ingle; José E Alés-Martínez; Angela M Cheung; Rowan T Chlebowski; Jean Wactawski-Wende; Anne McTiernan; John Robbins; Karen C Johnson; Lisa W Martin; Eric Winquist; Gloria E Sarto; Judy E Garber; Carol J Fabian; Pascal Pujol; Elizabeth Maunsell; Patricia Farmer; Karen A Gelmon; Dongsheng Tu; Harriet Richardson
Journal:  N Engl J Med       Date:  2011-06-04       Impact factor: 91.245

  1 in total
  2 in total

1.  Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy.

Authors:  Svasti Haricharan; Jie Dong; Sarah Hein; Jay P Reddy; Zhijun Du; Michael Toneff; Kimberly Holloway; Susan G Hilsenbeck; Shixia Huang; Rachel Atkinson; Wendy Woodward; Sonali Jindal; Virginia F Borges; Carolina Gutierrez; Hong Zhang; Pepper J Schedin; C Kent Osborne; David J Tweardy; Yi Li
Journal:  Elife       Date:  2013-12-31       Impact factor: 8.140

2.  Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Authors:  A N Johnston; W Bu; S Hein; S Garcia; L Camacho; L Xue; L Qin; C Nagi; S G Hilsenbeck; J Kapali; K Podsypanina; J Nangia; Y Li
Journal:  Breast Cancer Res       Date:  2018-05-19       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.